# Epsilon Energy Ltd.: financial statements, quarterly

EPSN · Nasdaq · CIK 1726126 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/epsn.md) · [Financials](/companies/epsn/financials.md) · [Filings](/companies/epsn/filings.md) · [Insiders](/companies/epsn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/epsn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6.3](/filings/0001558370-24-014668.md) | [8.6 d](/filings/0001558370-25-003308.md) | [8.0](/filings/0001558370-25-007742.md) | [7.3](/filings/0001558370-25-011374.md) | [7.3](/filings/0001104659-25-106988.md) | [8.9 d](/filings/0001104659-26-035794.md) | [16.2](/filings/0001104659-26-060245.md) | [11.6](/filings/0001104659-26-095013.md) | [9.0](/filings/0001104659-25-106988.md) | [14.8 d](/filings/0001104659-26-035794.md) | [25.6](/filings/0001104659-26-060245.md) | [18.3](/filings/0001104659-26-095013.md) |
| Operating income | $m | [0.7](/filings/0001558370-24-014668.md) | [1.7 d](/filings/0001558370-25-003308.md) | [1.4](/filings/0001558370-25-007742.md) | [1.2](/filings/0001558370-25-011374.md) | [0.2](/filings/0001104659-25-106988.md) | [0.6 d](/filings/0001104659-26-035794.md) | [7.2](/filings/0001104659-26-060245.md) | [0.8](/filings/0001104659-26-095013.md) | [0.6](/filings/0001104659-25-106988.md) | [(19.1) d](/filings/0001104659-26-035794.md) | [10.8](/filings/0001104659-26-060245.md) | [8.4](/filings/0001104659-26-095013.md) |
| Interest expense | $m | [0.0](/filings/0001558370-23-018582.md) | [0.0 d](/filings/0001558370-24-003645.md) | [0.0](/filings/0001558370-24-007320.md) | [0.0](/filings/0001558370-24-012054.md) | [0.0](/filings/0001104659-25-106988.md) | [0.0 d](/filings/0001104659-26-035794.md) | [0.0](/filings/0001104659-26-060245.md) | [0.0](/filings/0001104659-26-095013.md) | [0.0](/filings/0001104659-25-106988.md) | [0.6 d](/filings/0001104659-26-035794.md) | [0.9](/filings/0001104659-26-060245.md) | [0.9](/filings/0001104659-26-095013.md) |
| Income tax | $m | [0.7](/filings/0001558370-24-014668.md) | [0.9 d](/filings/0001558370-25-003308.md) | [0.1](/filings/0001558370-25-007742.md) | [0.5](/filings/0001558370-25-011374.md) | [0.4](/filings/0001104659-25-106988.md) | [0.7 d](/filings/0001104659-26-035794.md) | [1.7](/filings/0001104659-26-060245.md) | [1.8](/filings/0001104659-26-095013.md) | [0.6](/filings/0001104659-25-106988.md) | [(3.7) d](/filings/0001104659-26-035794.md) | [0.3](/filings/0001104659-26-060245.md) | [2.4](/filings/0001104659-26-095013.md) |
| Net income | $m | [0.4](/filings/0001558370-24-014668.md) | [2.6 d](/filings/0001558370-25-003308.md) | [1.5](/filings/0001104659-25-106988.md) | [0.8](/filings/0001104659-25-106988.md) | [0.4](/filings/0001104659-25-106988.md) | [(0.8) d](/filings/0001104659-26-035794.md) | [4.0](/filings/0001104659-26-095013.md) | [1.6](/filings/0001104659-26-095013.md) | [1.1](/filings/0001104659-25-106988.md) | [(12.4) d](/filings/0001104659-26-035794.md) | [0.7](/filings/0001104659-26-095013.md) | [7.1](/filings/0001104659-26-095013.md) |
| Diluted EPS | $ per share | [0.02](/filings/0001558370-24-014668.md) | not reported | [0.07](/filings/0001558370-25-007742.md) | [0.04](/filings/0001558370-25-011374.md) | [0.02](/filings/0001104659-25-106988.md) | not reported | [0.18](/filings/0001104659-26-060245.md) | [0.07](/filings/0001104659-26-095013.md) | [0.05](/filings/0001104659-25-106988.md) | not reported | [0.02](/filings/0001104659-26-060245.md) | [0.23](/filings/0001104659-26-095013.md) |
| Basic EPS | $ per share | [0.02](/filings/0001558370-24-014668.md) | not reported | [0.07](/filings/0001558370-25-007742.md) | [0.04](/filings/0001558370-25-011374.md) | [0.02](/filings/0001104659-25-106988.md) | not reported | [0.18](/filings/0001104659-26-060245.md) | [0.07](/filings/0001104659-26-095013.md) | [0.05](/filings/0001104659-25-106988.md) | not reported | [0.02](/filings/0001104659-26-060245.md) | [0.24](/filings/0001104659-26-095013.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [12.5](/filings/0001558370-23-018582.md) | [13.4](/filings/0001558370-25-003308.md) | [2.3](/filings/0001558370-24-007320.md) | [8.6](/filings/0001558370-24-012054.md) | [8.3](/filings/0001558370-24-014668.md) | [6.5](/filings/0001104659-26-035794.md) | [6.9](/filings/0001558370-25-007742.md) | [9.9](/filings/0001558370-25-011374.md) | [12.8](/filings/0001104659-25-106988.md) | [9.0](/filings/0001104659-26-095013.md) | [7.9](/filings/0001104659-26-060245.md) | [11.2](/filings/0001104659-26-095013.md) |
| Current assets | $m | [38.2](/filings/0001558370-23-018582.md) | [41.1](/filings/0001558370-25-003308.md) | [22.6](/filings/0001558370-25-007742.md) | [15.0](/filings/0001558370-25-011374.md) | [14.8](/filings/0001104659-25-106988.md) | [14.1](/filings/0001104659-26-035794.md) | [15.5](/filings/0001104659-26-060245.md) | [16.5](/filings/0001104659-26-095013.md) | [19.1](/filings/0001104659-25-106988.md) | [32.6](/filings/0001104659-26-095013.md) | [29.8](/filings/0001104659-26-060245.md) | [33.8](/filings/0001104659-26-095013.md) |
| Total assets | $m | [120](/filings/0001558370-23-018582.md) | [124](/filings/0001558370-25-003308.md) | [125](/filings/0001558370-25-007742.md) | [121](/filings/0001558370-25-011374.md) | [122](/filings/0001104659-25-106988.md) | [120](/filings/0001104659-26-035794.md) | [126](/filings/0001104659-26-060245.md) | [124](/filings/0001104659-26-095013.md) | [126](/filings/0001104659-25-106988.md) | [228](/filings/0001104659-26-095013.md) | [226](/filings/0001104659-26-060245.md) | [236](/filings/0001104659-26-095013.md) |
| Current liabilities | $m | [5.2](/filings/0001558370-23-018582.md) | [7.9](/filings/0001558370-25-003308.md) | [9.7](/filings/0001558370-24-007320.md) | [6.1](/filings/0001558370-24-012054.md) | [7.3](/filings/0001558370-24-014668.md) | [7.0](/filings/0001104659-26-035794.md) | [9.3](/filings/0001558370-25-007742.md) | [7.4](/filings/0001558370-25-011374.md) | [9.9](/filings/0001104659-25-106988.md) | [25.0](/filings/0001104659-26-095013.md) | [27.6](/filings/0001104659-26-060245.md) | [35.1](/filings/0001104659-26-095013.md) |
| Total liabilities | $m | [20.3](/filings/0001558370-23-018582.md) | [23.4](/filings/0001558370-25-003308.md) | [25.2](/filings/0001558370-24-007320.md) | [21.5](/filings/0001558370-24-012054.md) | [23.4](/filings/0001558370-24-014668.md) | [23.7](/filings/0001104659-26-035794.md) | [25.8](/filings/0001558370-25-007742.md) | [23.4](/filings/0001558370-25-011374.md) | [26.1](/filings/0001104659-25-106988.md) | [104](/filings/0001104659-26-095013.md) | [102](/filings/0001104659-26-060245.md) | [107](/filings/0001104659-26-095013.md) |
| Shareholders' equity | $m | [99.5](/filings/0001558370-24-014668.md) | [101](/filings/0001104659-26-035794.md) | [99.9](/filings/0001104659-25-106988.md) | [99.6](/filings/0001104659-25-106988.md) | [98.4](/filings/0001104659-25-106988.md) | [96.7](/filings/0001104659-26-095013.md) | [99.7](/filings/0001104659-26-095013.md) | [100](/filings/0001104659-26-095013.md) | [100](/filings/0001104659-25-106988.md) | [125](/filings/0001104659-26-095013.md) | [124](/filings/0001104659-26-095013.md) | [130](/filings/0001104659-26-095013.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [4.2 d](/filings/0001558370-24-014668.md) | [3.8 d](/filings/0001558370-25-003308.md) | [3.7](/filings/0001558370-25-007742.md) | [5.4 d](/filings/0001558370-25-011374.md) | [2.7 d](/filings/0001104659-25-106988.md) | [5.0 d](/filings/0001104659-26-035794.md) | [8.6](/filings/0001104659-26-060245.md) | [8.3 d](/filings/0001104659-26-095013.md) | [4.0 d](/filings/0001104659-25-106988.md) | [(0.3) d](/filings/0001104659-26-035794.md) | [10.1](/filings/0001104659-26-060245.md) | [12.3 d](/filings/0001104659-26-095013.md) |
| Share repurchases | $m | [2.6 d](/filings/0001558370-24-014668.md) | [0.4 d](/filings/0001558370-25-003308.md) | [1.2](/filings/0001558370-25-007742.md) | [0.0 d](/filings/0001558370-25-011374.md) | [0.6 d](/filings/0001104659-25-106988.md) | [0.0 d](/filings/0001104659-26-035794.md) | [0.0](/filings/0001558370-25-007742.md) | [0.0 d](/filings/0001558370-25-011374.md) | [0.0 d](/filings/0001104659-25-106988.md) | [0.0 d](/filings/0001104659-26-035794.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [23.2](/filings/0001558370-23-018582.md) | [23.0](/filings/0001558370-24-007320.md) | [22.8](/filings/0001558370-24-012054.md) | [22.2](/filings/0001558370-24-014668.md) | [22.0](/filings/0001558370-25-007742.md) | [22.0](/filings/0001558370-25-011374.md) | [22.2](/filings/0001104659-25-106988.md) | [22.1](/filings/0001104659-26-060245.md) | [22.2](/filings/0001104659-26-095013.md) | [22.2](/filings/0001104659-25-106988.md) | [30.3](/filings/0001104659-26-060245.md) | [30.4](/filings/0001104659-26-095013.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 30,283,779 at 2026-08-11, from the cover of the [10-Q filed 2026-08-12](/filings/0001104659-26-095013.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.